Positive results for ruxolitinib in graft-versus-host disease
Incyte Corporation has announced promising results for ruxolitinib in the Novartis-sponsored Phase III trial REACH2 of patients with steroid-refractory acute...
Focus:
-
![Expanding HPV vaccination to boys: what more needs to be done?]()
Expanding HPV vaccination to boys: what more needs to be done?
-
![Mundipharma demonstrates superiority of non-opioid Penthrox in relieving pain]()
Mundipharma demonstrates superiority of non-opioid Penthrox in relieving pain
-
![ConcePTION: tackling the unknowns of medication in pregnancy]()
ConcePTION: tackling the unknowns of medication in pregnancy
-
![Queen’s Speech 2019: UK seeks to strengthen NHS and life sciences]()
Queen’s Speech 2019: UK seeks to strengthen NHS and life sciences
-
![How do cancer cells communicate and can it help us catch them?]()
How do cancer cells communicate and can it help us catch them?
-
![Pfizer’s JAK1 inhibitor performs well in atopic dermatitis]()
Pfizer’s JAK1 inhibitor performs well in atopic dermatitis
Expert commentary & analysis from GlobalData
Myasthenia gravis severity is more grave in the US
Eli Lilly set to lead migraine market with new first-in-class drug approval
UCB takes over Ra Pharma to expand myasthenia gravis offering
From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes
Most Read
Company releases
Nymi to Host ‘Can Opposites Attract?’ Webinar
Balancing and finding productivity in opposites. In companies, compliance and security are two poles moving away from one another.
SEC Signature Dir is ATEX certificated, Thanks to RSD
Modality Solutions Ranks as One of Houston’s Fastest-Growing Companies
Modality Solutions, a biopharmaceutical cold chain engineering firm, is pleased to announce it made its first appearance on the Houston...
Alconox to Exhibit at ISPE 2019
Goodly Innovations to Appear at AWE on October 17-18
Goodly Innovations fast-tracks development of OptiworX, the contemporary AR Solution for the biotech and pharmaceutical...
Company whitepapers
Aqueous Cleaning in Pharmaceutical Manufacturing
AlconoxModular Cleanrooms
MECART CleanroomsDefining Ideal Modular Design for Effective Pharmaceutical Packaging
DividellaFinnair COOL Nordic Cargo Hub
FinnairMeasurement Uncertainty in GxP Temperature Mapping
MetrotekaFreeze-Drying Systems and Freeze-Thaw Units
HOF SonderanlagenbauIKA Laboratory Equipment Catalogue
IKA-Werke GmbH & CoCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Kite Pharma’s Biopharmaceutical Manufacturing Facility
Kite Pharma, a subsidiary of Gilead Sciences, announced about the construction of its new biopharmaceutical manufacturing facility in Hoofddorp, the Netherlands.
PTC Therapeutics’ Biologics Facility
CGT Catapult Manufacturing Facility Expansion
QuVa Pharma’s Pharmaceutical Manufacturing Facility Expansion, New Jersey
Pfizer’s Gene Therapy Manufacturing Facility Expansion, North Carolina
Clinical Trials
Positive results for ruxolitinib in graft-versus-host disease
Incyte Corporation has announced promising results for ruxolitinib in the Novartis-sponsored Phase III trial REACH2 of patients with steroid-refractory acute graft-versus-host disease.
Mundipharma demonstrates superiority of non-opioid Penthrox in relieving pain
Pfizer’s JAK1 inhibitor performs well in atopic dermatitis
Keytruda approved in China as a monotherapy for NSCLC
AstraZeneca and Merck announce full results for PARP inhibitor Lynparza
Design
USPTO reverses decision regarding interfering CRISPR patents
The Patient Trial and Appeal Board (PTAB) of the US Patent and Trademark Office (USPTO) has changed its stance regarding an interference between ten patent...
Dassault to enhance clinical tech with $5.8bn Medidata acquisition
ProAmpac updates child-resistant pouch product line
Drug Development
Positive results for ruxolitinib in graft-versus-host disease
Incyte Corporation has announced promising results for ruxolitinib in the Novartis-sponsored Phase III trial REACH2 of patients with steroid-refractory acute graft-versus-host disease.
Ipsen gains licence to Blueprint Medicines’ FOP drug candidate
Pfizer’s JAK1 inhibitor performs well in atopic dermatitis
Shionogi and Hsiri to develop mycobacterial disease therapies
Alexion and Stealth to develop elamipretide for mitochondrial diseases
Market Data
ICER finds lack of evidence to support blockbuster drug price hikes
A report by the Institute of Clinical and Economic Review (ICER) has determined that seven of the nine top-selling drugs in the US had limited...
J&J’s Janssen to pay $8bn in Risperdal anti-psychotic drug lawsuit
UK’s CMA accuses Aspen of price hike for Addison’s disease drug
UK’s NAO warns of uncertain medicines supply in no-deal Brexit
NICE rejects Novartis’ migraine drug Aimovig over data concerns
Technology
Sanofi opens digital manufacturing facility in the US
French pharmaceutical giant Sanofi has opened a digital manufacturing facility at Framingham in Massachusetts, the US for continuous production of biologics.
Novartis teams up with Microsoft for AI drug development
Takeda and Evotec initiate drug discovery collaboration
Atomwise inks four new deals for AI-based drug discovery
Gene therapy biotech Genenta raises €13.2m in funding round
kinaxis: Your recommended content
Challenges for the life sciences supply chain with Brexit
DJA: Your recommended content
Electrolab: Pharmaceutical testing equipment
How Electronic Inspection Sensors Prevented A Potentially Extremely Costly Product Recall
View whitepaper
NSF Pharma: Your recommended content
The importance of GMP auditing services
Six essential ways to improve your pharmaceutical quality system
View whitepaper
ILC Dover: Your recommended content
How CMO/CDMO facilities can gain value with single use containment
Choosing Single-Use Flexible Containment Systems For Charging And Offloading Transfer Operations
View whitepaper
Hapa: Your recommended content
The Ferrari of medical machinery: How one solution impressed Arimpek
Process For Low Migration Qualification In The Food, Pharma And Medical Industry
View whitepaper
Medel Pharm: Your recommended content
Innovative technologies in tabletting development
Covance: Your recommended content
Deciphering real world data to accelerate clinical trials
Covance: Your recommended content
How patient centricity is enabling the reality of virtual trials and mHealth
Covance: Your recommended content
Covance: Your recommended content
Go Top